Machine learning revealed ferroptosis features and ferroptosis-related gene-based immune microenvironment in lung adenocarcinoma. (1st June 2023)

• Record Type: Journal Article
• Authors: Luo, Lianxiang; Chen, Xinming; Huang, Fangfang
• Is Part Of: Chemico-biological interactions. Volume 378(2023)
• Publication Date: 2023-06-01
• Subjects: Ferroptosis -- Lung adenocarcinoma -- Machine learning -- Immunotherapy; Biochemistry -- Periodicals; Toxicological chemistry -- Periodicals; Biochemistry -- Periodicals; Biologie moléculaire -- Périodiques; Biochimie -- Périodiques; Toxicologie biochimique -- Périodiques; 572
• DOI: 10.1016/j.cbi.2023.110471
• Languages: English
• ISSNs: 0009-2797

Abstract

Abstract: Ferroptosis has been identified as a novel type of programmed cell death that has a major effect on the development of lung adenocarcinoma. Nevertheless, there has yet to be a clear set of therapeutic targets based on ferroptosis. This study seeks to employ machine learning methods to determine the regulators of ferroptosis in LUAD. 318 LUAD samples were investigated to determine three ferroptosis molecular phenotypes in LUAD, and then Boruta dimensionality reduction combined with principal component analysis was used to measure the ferroptosis regulation score (FRS) of patients. We additionally presented DeepFerr, a deep learning neural network model, which used the transcriptome map of 11 ferroptosis regulators to predict ferroptosis in LUAD. LASSO, SVM-RFE and elastic net were used to dissect the differential ferroptosis regulators, and the eight pivotal ferroptosis regulators have considerable ferroptosis prediction ability. It was established that RRM2 and AURKA are key suppressors of ferroptosis, and the depletion of RRM2 and AURKA caused an increase in ferroptosis in H358 cells. In addition, not only did they act as pro-proliferative factors that hindered immune infiltration in LUAD, but they were also essential for anti-PD1 therapy and chemotherapy. In summary, this research confirms the regulatory role of RRM2 and AURKA in ferroptosis, and could be useful in predicting individualized treatment for patients with LUAD. Highlights: We developed a machine learning model to identify genes that regulate ferroptosis in lung adenocarcinoma. RRM2 and AURKA have been identified as a negative regulator of ferroptosis. RRM2 and AURKA are associated with anti-PD1 immunotherapy in lung adenocarcinoma. RRM2 and AURKA are potential candidates for drug targeting in lung adenocarcinoma.